Core Viewpoint - The article discusses the tightening regulations on medical advertising in response to the increasing prevalence of misleading advertisements disguised as health information, particularly in the context of the internet's rapid development [1][3]. Summary by Sections Medical Advertising Regulation Challenges - Medical advertising has become more complex with the rise of the internet, leading to a blurring of lines between health education and advertising [1]. - In the first half of the year, regulatory authorities handled 1,666 cases of illegal medical advertising, imposing fines totaling 12.78 million yuan [1]. Introduction of the Recognition Guidelines - The State Administration for Market Regulation, in collaboration with the National Health Commission and the National Administration of Traditional Chinese Medicine, has developed the "Medical Advertising Recognition Guidelines" to clarify what constitutes medical advertising [3][4]. - The guidelines emphasize the importance of legitimate advertising entities and aim to address issues related to unqualified "black hospitals" and "black doctors" misleading the public [3]. Key Changes in the Guidelines - The guidelines prohibit any entity or individual, except legally established medical institutions, from publishing medical advertisements [4]. - The previous ambiguous definitions regarding promotional activities and health education have been removed, tightening the criteria for what constitutes advertising [4]. - The guidelines specify that linking health education content to medical services or products constitutes disguised advertising [4]. Focus on Internet Platforms - The rise of internet platforms has increased the volume of medical advertising, making it difficult for consumers to distinguish between advertising and educational content [6]. - Recent policies in Beijing aim to enhance compliance and promote legal awareness regarding medical advertising on digital platforms [6]. Collaborative Regulatory Efforts - The guidelines call for a coordinated approach among various regulatory bodies to effectively manage medical advertising [8]. - Local market supervision bureaus are collaborating with health and law enforcement departments to create a comprehensive regulatory network [8]. - A tiered regulatory approach is being implemented to avoid one-size-fits-all enforcement, allowing for leniency in minor violations [8].

Core Viewpoint - The regulatory authority emphasizes the need for life insurance companies to enhance the sustainability of dividend insurance operations and protect consumer rights by adhering to asset-liability management principles [1][2][4]. Group 1: Regulatory Requirements - Companies are required to balance the predetermined interest rates of dividend insurance with floating returns and actual dividend realization rates, considering the asset allocation characteristics and actual investment returns of each account [2]. - The regulatory body will strengthen data monitoring and impose measures such as regulatory interviews, orders for rectification, and rating deductions for non-compliance [2][6]. Group 2: Dividend Insurance Overview - Dividend insurance refers to life insurance products where companies distribute a portion of their operating surplus to policyholders [3]. - In a long-term declining interest rate environment, insurance companies are increasing the sales of dividend insurance, making dividend levels a competitive focus in the industry [4]. Group 3: Industry Analysis - The new standards are clear and emphasize the regulation and sustainability of dividends, which is beneficial for the long-term healthy development of the dividend insurance sector amid company transformations [5]. - Last year, the overall dividend level for most life insurance companies ranged between 3% and 3.2% [8].